论文已发表
提 交 论 文
注册即可获取Ebpay生命的最新动态
注 册
IF 收录期刊
多发性咖啡牛奶斑的临床特征及其在遗传性疾病早期筛查中的潜在意义
Authors Chen T, Wu J, Yang X, Xia Z, Yang R
Received 6 February 2025
Accepted for publication 17 May 2025
Published 30 May 2025 Volume 2025:18 Pages 1339—1347
DOI http://doi.org/10.2147/CCID.S521076
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jeffrey Weinberg
Tong Chen,1– 3 Jiamin Wu,1 Xin Yang,2 Zhikuan Xia,1,2 Rongya Yang1,2
1The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, People’s Republic of China; 2Department of Dermatology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, 100080, People’s Republic of China; 3Department of Dermatology, Longgang Central Hospital, Shenzhen, Guangdong, 518116, People’s Republic of China
Correspondence: Rongya Yang, Email drYangRongya@outlook.com; yangrya@sina.com Zhikuan Xia, Email drXiaZhikuan@outlook.com; sum7@sina.com
Background: Café-au-lait macules (CALMs) are common skin manifestations, and their number and distribution may indicate potential genetic disorders, such as Neurofibromatosis Type 1 (NF1). This study aimed to investigate the clinical characteristics of multiple CALMs and their significance in the early screening of genetic disorders.
Methods: This retrospective study included 98 patients diagnosed between May 2021 and May 2024 in two hospitals. Patients were divided into three groups based on the number of CALMs and whether other skin manifestations were present: Group 1 (≥ 6 CALMs with other skin manifestations), Group 2 (≥ 6 CALMs without other skin manifestations), and Group 3 (< 6 CALMs without other skin manifestations). Detailed clinical evaluations and imaging examinations were conducted to record the number, size, distribution of CALMs, and associated symptoms. Multivariate logistic regression analysis was performed to explore the relationship between CALMs and other systemic symptoms.
Results: Group 1 patients showed significantly higher incidences of neurological symptoms (eg, neurofibromas 54%, P < 0.001) and skeletal system symptoms (eg, bone deformities 38%, P = 0.001) compared to Groups 2 and 3. Imaging examinations revealed an abnormality rate of 90% in Group 1 (P < 0.001). Logistic regression analysis indicated that the number of CALMs (≥ 10) was significantly associated with neurological (OR = 7.664, P = 0.001) and skeletal system symptoms (OR = 4.623, P = 0.014). The distribution of CALMs on the face and neck also showed a certain influence on symptoms.
Conclusion: The number and distribution of CALMs are significant in the early screening of genetic diseases, particularly in identifying patients with potential neurological and skeletal system abnormalities.
Keywords: café-au-lait macules, neurofibromatosis type 1, genetic disorders, early screening